Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joel D Allen

Showing results (31-40 of 91) with videos related to

Pageof 10
Sort By:
Biorxiv : the Preprint Server for Biology|March 10, 2025
Rational design of next-generation filovirus vaccines with glycoprotein stabilization, nanoparticle display, and glycan modificationYi-Zong Lee, Yi-Nan Zhang, Maddy L Newby, et al.
Nature Communications|December 12, 2025
Rational design of next-generation filovirus vaccines combining glycoprotein stabilization and nanoparticle display with glycan modificationYi-Zong Lee, Yi-Nan Zhang, Maddy L Newby, et al.
Vaccines|February 26, 2025
The Design and Immunogenicity of an HIV-1 Clade C Pediatric Envelope Glycoprotein Stabilized by Multiple PlatformsSanjeev Kumar, Iván Del Moral-Sánchez, Swarandeep Singh, et al.
Journal of Molecular Biology|October 31, 2021
Glycosylation and Serological Reactivity of an Expression-enhanced SARS-CoV-2 Viral Spike MimeticHimanshi Chawla, Sian E Jossi, Sian E Faustini, et al.
Blood|September 2, 2025
The Origin, Diagnosis, and Prognosis of Oligomannose-Type Diffuse Large B-Cell LymphomaDylan James Tatterton, Maddy L Newby, Joel D Allen, et al.
Plos Pathogens|October 22, 2021
Engineering well-expressed, V2-immunofocusing HIV-1 envelope glycoprotein membrane trimers for use in heterologous prime-boost vaccine regimensEmma T Crooks, Francisco Almanza, Alessio D'Addabbo, et al.
Plos Pathogens|March 22, 2021
A cross-neutralizing antibody between HIV-1 and influenza virusChang-Chun D Lee, Yasunori Watanabe, Nicholas C Wu, et al.
Cardiovascular Research|June 16, 2022
Preferential uptake of SARS-CoV-2 by pericytes potentiates vascular damage and permeability in an organoid model of the microvasculatureAbdullah O Khan, Jasmeet S Reyat, Harriet Hill, et al.
NPJ Vaccines|March 1, 2022
High thermostability improves neutralizing antibody responses induced by native-like HIV-1 envelope trimersIván Del Moral-Sánchez, Rebecca A Russell, Edith E Schermer, et al.
Cell Reports|August 23, 2018
Site-Specific Glycosylation of Virion-Derived HIV-1 Env Is Mimicked by a Soluble Trimeric ImmunogenWeston B Struwe, Elena Chertova, Joel D Allen, et al.
Pageof 10

Showing results (31-40 of 91) with videos related to

Sort By:
Pageof 10
Biorxiv : the Preprint Server for Biology|March 10, 2025
Rational design of next-generation filovirus vaccines with glycoprotein stabilization, nanoparticle display, and glycan modificationYi-Zong Lee, Yi-Nan Zhang, Maddy L Newby, et al.
Nature Communications|December 12, 2025
Rational design of next-generation filovirus vaccines combining glycoprotein stabilization and nanoparticle display with glycan modificationYi-Zong Lee, Yi-Nan Zhang, Maddy L Newby, et al.
Vaccines|February 26, 2025
The Design and Immunogenicity of an HIV-1 Clade C Pediatric Envelope Glycoprotein Stabilized by Multiple PlatformsSanjeev Kumar, Iván Del Moral-Sánchez, Swarandeep Singh, et al.
Journal of Molecular Biology|October 31, 2021
Glycosylation and Serological Reactivity of an Expression-enhanced SARS-CoV-2 Viral Spike MimeticHimanshi Chawla, Sian E Jossi, Sian E Faustini, et al.
Blood|September 2, 2025
The Origin, Diagnosis, and Prognosis of Oligomannose-Type Diffuse Large B-Cell LymphomaDylan James Tatterton, Maddy L Newby, Joel D Allen, et al.
Plos Pathogens|October 22, 2021
Engineering well-expressed, V2-immunofocusing HIV-1 envelope glycoprotein membrane trimers for use in heterologous prime-boost vaccine regimensEmma T Crooks, Francisco Almanza, Alessio D'Addabbo, et al.
Plos Pathogens|March 22, 2021
A cross-neutralizing antibody between HIV-1 and influenza virusChang-Chun D Lee, Yasunori Watanabe, Nicholas C Wu, et al.
Cardiovascular Research|June 16, 2022
Preferential uptake of SARS-CoV-2 by pericytes potentiates vascular damage and permeability in an organoid model of the microvasculatureAbdullah O Khan, Jasmeet S Reyat, Harriet Hill, et al.
NPJ Vaccines|March 1, 2022
High thermostability improves neutralizing antibody responses induced by native-like HIV-1 envelope trimersIván Del Moral-Sánchez, Rebecca A Russell, Edith E Schermer, et al.
Cell Reports|August 23, 2018
Site-Specific Glycosylation of Virion-Derived HIV-1 Env Is Mimicked by a Soluble Trimeric ImmunogenWeston B Struwe, Elena Chertova, Joel D Allen, et al.
Pageof 10